Therapeutic targeting of hepatic ACSL4 ameliorates NASH in mice

Duan, JJ; Wang, Z; Duan, R; Yang, CXH; Zhao, RL; Feng, Q; Qin, YY; Jiang, JW; Gu, SY; Lv, KY; Zhang, LB; He, BX; Birnbaumer, L; Yang, S; Chen, Z; Yang, Y

Chen, Z; Yang, Y (通讯作者),China Pharmaceut Univ, Ctr New Drug Safety Evaluat & Res, State Key Lab Nat Med, 639 Longmian Ave, Nanjing 211198, Jiangsu, Peoples R China.

HEPATOLOGY, 2022; 75 (1): 140

Abstract

Background and Aims Globally, NAFLD is one of the most common liver disorders, with an estimated prevalence rate of more than 30% in men and 15% in wo......

Full Text Link